
For IND-bound programs that need clarity on what comes next - and why.
The Nonclinical Strategy Audit is a senior-level assessment of whether your nonclinical program supports the decisions you’re about to make.

_edited_edited_ed.png)
MORE DETAILS
This audit is for:
-
Pre-IND and IND-bound companies
-
Programs selecting species and models now
-
Teams outsourcing all tox to CROs
-
Founders who want nonclinical leadership
-
Established startups without in-house tox
This audit provides:
-
Clear hierarchy of nonclinical risks
-
Alignment of data, interpretation, and clinical intent
-
Identification of study gaps and decision blind spots
-
An IND-aligned nonclinical narrative
Seeking fractional tox support?
The Nonclinical Strategy Audit is a great first step for teams seeking Fractional Toxicology Support. It allows for a thorough assessment of your nonclinical program to ensure alignment and fit. Fractional Toxicology Leadership is intentionally capped at three clients to maintain the depth and quality of support.

What Happens After You Book?
Once your audit is booked, a short onboarding sequence is triggered to ensure everything moves quickly and efficiently.
You’ll receive:
-
A payment receipt
-
A follow-up email outlining next steps, including:
-
A link to execute an NDA via DocuSign (or the option to provide your own)
-
Secure access to a dedicated Box folder for document upload
-
A link to schedule a 30-minute kickoff meeting
-
As long as all materials are uploaded before the kickoff meeting, you can expect the full audit review document within 5 business days.
.png)

